NCT05052294View on ClinicalTrials.gov

COVID-19 Antibody Responses in Cystic Fibrosis

Active, not recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

September 13, 2021

Primary Completion Date

June 1, 2025

Study Completion Date

June 1, 2025

Conditions
Cystic Fibrosis
Trial Locations (2)

15006

University Hospital Motol, Prague

61300

Brno University Hospital, Brno

All Listed Sponsors
collaborator

Brno University Hospital

OTHER

lead

University Hospital, Motol

OTHER

NCT05052294 - COVID-19 Antibody Responses in Cystic Fibrosis | Biotech Hunter | Biotech Hunter